Pembrolizumab in Combination with Radiotherapy for Metastatic Melanoma - Introducing the PERM Trial
Clin Oncol (R Coll Radiol)
.
2018 Apr;30(4):201-203.
doi: 10.1016/j.clon.2018.01.001.
Authors
K Yip
1
,
A Melcher
2
,
K Harrington
2
,
T Illidge
3
,
J Nobes
4
,
A Webster
5
,
D Smith
6
,
P Lorigan
3
,
P Nathan
7
,
J Larkin
6
Affiliations
1
Ipswich Hospital, Ipswich, UK. Electronic address:
[email protected]
.
2
Institute of Cancer Research, Sutton, London, UK; The Royal Marsden Hospital, Chelsea, London, UK.
3
University of Manchester, Manchester, UK; The Christie NHS Foundation Trust, Withington, Manchester, UK.
4
Norfolk and Norwich University Hospital, Norwich, UK.
5
Radiotherapy Trials Quality Assurance Group, Mount Vernon Cancer Centre, Northwood, UK.
6
The Royal Marsden Hospital, Chelsea, London, UK.
7
Mount Vernon Cancer Centre, Northwood, UK.
PMID:
29402599
DOI:
10.1016/j.clon.2018.01.001
No abstract available
Publication types
Editorial
Grants and funding
17737/CRUK_/Cancer Research UK/United Kingdom
19306/CRUK_/Cancer Research UK/United Kingdom